English
简体中文
Total: £ 56.28
Published Date: 2025-04-08 | Pages: 95 | Tables: 89 | Pharma & Healthcare
The global market for Bacille Calmette-Guerin Vaccine was valued at US$ 80.4 million in the year 2024 and is projected to reach a revised size of US$ 99 million by 2031, growing at a CAGR of 3.1% during the forecast period.
The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.
The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.
A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine.
The Bacille Calmette-Guerin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacille Calmette-Guerin Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacille Calmette-Guerin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine
Segment by Application
Self-Procurement
UNICEF
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacille Calmette-Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Bacille Calmette-Guerin Vaccine Market Overview
1.1 Product Definition
1.2 Bacille Calmette-Guerin Vaccine by Type
1.2.1 Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Bacille Calmette-Guerin Vaccine by Application
1.3.1 Global Bacille Calmette-Guerin Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Bacille Calmette-Guerin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guerin Vaccine Revenue 2020-2031
1.4.2 Global Bacille Calmette-Guerin Vaccine Sales 2020-2031
1.4.3 Global Bacille Calmette-Guerin Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guerin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bacille Calmette-Guerin Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bacille Calmette-Guerin Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Date of Enter into This Industry
2.8 Global Bacille Calmette-Guerin Vaccine Market Competitive Situation and Trends
2.8.1 Global Bacille Calmette-Guerin Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bacille Calmette-Guerin Vaccine Players Market Share by Revenue
2.8.3 Global Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bacille Calmette-Guerin Vaccine Market Scenario by Region
3.1 Global Bacille Calmette-Guerin Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2020-2031
3.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2020-2025
3.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2026-2031
3.3 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2020-2031
3.3.1 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2020-2025
3.3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2026-2031
3.4 North America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2020-2031)
3.4.3 North America Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2020-2031)
3.5.3 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guerin Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Bacille Calmette-Guerin Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2020-2031)
4.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2020-2025)
4.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Type (2026-2031)
4.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2020-2031)
4.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2020-2025)
4.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2026-2031)
4.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Bacille Calmette-Guerin Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2020-2031)
5.1.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2020-2025)
5.1.2 Global Bacille Calmette-Guerin Vaccine Sales by Application (2026-2031)
5.1.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2020-2031)
5.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2020-2025)
5.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2026-2031)
5.2.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Bacille Calmette-Guerin Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Company Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Company Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Company Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Company Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Company Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.7.1 China National Biotec Company Information
6.7.2 China National Biotec Description and Business Overview
6.7.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Company Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Company Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
6.10 Ataulpho de Paiva
6.10.1 Ataulpho de Paiva Company Information
6.10.2 Ataulpho de Paiva Description and Business Overview
6.10.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio
6.10.5 Ataulpho de Paiva Recent Developments/Updates
6.11 IVAC – Institute of Vaccines and Medical Biologicals
6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
6.11.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio
6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
6.12 Queen Saovabha Mem. Inst
6.12.1 Queen Saovabha Mem. Inst Company Information
6.12.2 Queen Saovabha Mem. Inst Description and Business Overview
6.12.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio
6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
6.13 Microgen
6.13.1 Microgen Company Information
6.13.2 Microgen Description and Business Overview
6.13.3 Microgen Bacille Calmette-Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Microgen Bacille Calmette-Guerin Vaccine Product Portfolio
6.13.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guerin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guerin Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guerin Vaccine Production Mode & Process Analysis
7.4 Bacille Calmette-Guerin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guerin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guerin Vaccine Distributors
7.5 Bacille Calmette-Guerin Vaccine Customer Analysis
8 Bacille Calmette-Guerin Vaccine Market Dynamics
8.1 Bacille Calmette-Guerin Vaccine Industry Trends
8.2 Bacille Calmette-Guerin Vaccine Market Drivers
8.3 Bacille Calmette-Guerin Vaccine Market Challenges
8.4 Bacille Calmette-Guerin Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bacille Calmette-Guerin Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bacille Calmette-Guerin Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bacille Calmette-Guerin Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bacille Calmette-Guerin Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Bacille Calmette-Guerin Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacille Calmette-Guerin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guerin Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bacille Calmette-Guerin Vaccine Sales by Region (2020-2025) & (K Dose)
Table 18. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Bacille Calmette-Guerin Vaccine Sales by Region (2026-2031) & (K Dose)
Table 20. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Bacille Calmette-Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bacille Calmette-Guerin Vaccine Sales by Country (2020-2025) & (K Dose)
Table 27. North America Bacille Calmette-Guerin Vaccine Sales by Country (2026-2031) & (K Dose)
Table 28. North America Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bacille Calmette-Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bacille Calmette-Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Bacille Calmette-Guerin Vaccine Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Bacille Calmette-Guerin Vaccine Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bacille Calmette-Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Type (2020-2025)
Table 51. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Type (2026-2031)
Table 52. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Application (2020-2025)
Table 61. Global Bacille Calmette-Guerin Vaccine Sales (K Dose) by Application (2026-2031)
Table 62. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Merck Bacille Calmette-Guerin Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Company Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Company Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Serum Institute of India Bacille Calmette-Guerin Vaccine Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Company Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. AJ Vaccines Bacille Calmette-Guerin Vaccine Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Company Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. BioFarma Bacille Calmette-Guerin Vaccine Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Company Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Company Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. China National Biotec Bacille Calmette-Guerin Vaccine Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Company Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Biomed Lublin Bacille Calmette-Guerin Vaccine Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Company Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Ataulpho de Paiva Company Information
Table 116. Ataulpho de Paiva Description and Business Overview
Table 117. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. IVAC – Institute of Vaccines and Medical Biologicals Company Information
Table 121. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
Table 122. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product
Table 124. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
Table 125. Queen Saovabha Mem. Inst Company Information
Table 126. Queen Saovabha Mem. Inst Description and Business Overview
Table 127. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product
Table 129. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 130. Microgen Company Information
Table 131. Microgen Description and Business Overview
Table 132. Microgen Bacille Calmette-Guerin Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Microgen Bacille Calmette-Guerin Vaccine Product
Table 134. Microgen Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Bacille Calmette-Guerin Vaccine Distributors List
Table 138. Bacille Calmette-Guerin Vaccine Customers List
Table 139. Bacille Calmette-Guerin Vaccine Market Trends
Table 140. Bacille Calmette-Guerin Vaccine Market Drivers
Table 141. Bacille Calmette-Guerin Vaccine Market Challenges
Table 142. Bacille Calmette-Guerin Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bacille Calmette-Guerin Vaccine
Figure 2. Global Bacille Calmette-Guerin Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bacille Calmette-Guerin Vaccine Market Share by Type: 2024 & 2031
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Bacille Calmette-Guerin Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Bacille Calmette-Guerin Vaccine Market Share by Application: 2024 & 2031
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global Bacille Calmette-Guerin Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bacille Calmette-Guerin Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Bacille Calmette-Guerin Vaccine Sales (2020-2031) & (K Dose)
Figure 14. Global Bacille Calmette-Guerin Vaccine Average Price (US$/Dose) & (2020-2031)
Figure 15. Bacille Calmette-Guerin Vaccine Report Years Considered
Figure 16. Bacille Calmette-Guerin Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Bacille Calmette-Guerin Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Bacille Calmette-Guerin Vaccine Players: Market Share by Revenue in Bacille Calmette-Guerin Vaccine in 2024
Figure 19. Bacille Calmette-Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Bacille Calmette-Guerin Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. United States Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Bacille Calmette-Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Type (2020-2031)
Figure 55. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Bacille Calmette-Guerin Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Bacille Calmette-Guerin Vaccine by Application (2020-2031)
Figure 58. Global Bacille Calmette-Guerin Vaccine Price (US$/Dose) by Application (2020-2031)
Figure 59. Bacille Calmette-Guerin Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
